Healthcare
Live Price
Offline$30.54
+1.83% today
1Y Change
-8.26%
Window
Jun 27, 2025 → Jun 17, 2026
Coverage: 245 bars · Jun 27, 2025 → Jun 17, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Immunocore Holdings plc (IMCR) is a Healthcare stock with a market cap of $1.41B and listed on NASDAQ. The stock last traded around $30.54 and down 8.3% across the available one-year price window (Jun 27, 2025 → Jun 17, 2026). Baseline metrics include revenue growth of +20.0%, EPS growth of +48.0%, a dividend yield of 0.0%. What stands out right now is revenue +20.0%, EPS +48.0%, free cash flow -153.6% with operating margin -10.8% and ROIC -4.9%. Valuation is more restrained than many high-expectation growth names at price/sales 3.8. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines IMCR price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Edge
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
Relative Read
IMCR is 28.76 pts behind over the shared 1Y window.
IMCR had 21.76 pts deeper max drawdown than SPY.
IMCR beat SPY in 0 of 2 calendar years shown and trailed in 2.
IMCR
-8.26%
Normalized return
SPY
+20.50%
S&P 500
Excess Return
-28.76 pts
Relative to SPY
IMCR Max Drawdown
-30.90%
Trailing 1Y
SPY Max Drawdown
-9.13%
Trailing 1Y
Uses the longest available daily history for IMCR and SPY.
| Year | IMCR | SPY | Excess | Leader |
|---|---|---|---|---|
| 2026 | -15.48% | +6.71% | -22.19 pts | SPY |
| 2025 | +9.58% | +11.73% | -2.15 pts | SPY |
Unable to load analyst forecasts.
Timed out loading forecasts for IMCR
Next Step
Forecasts are most valuable when they sit beside comparisons, earnings setup, and the rest of the business story.